SCHEMBL7835593

SCHEMBL7835593

Cn1[c]cc2cc(Nc3ccccc3)ccc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.49
HSD17B10 Q99714 4/20 0.49
CYP3A4 P08684 4/20 0.49
HPGD P15428 2/20 0.49
APP P05067 1/20 0.43
MAPT P10636 4/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
AR P10275 1/20 0.42
TSHR P16473 3/20 0.42
TDP1 Q9NUW8 3/20 0.42
ALOX12 P18054 3/20 0.42
L3MBTL1 Q9Y468 3/20 0.42
ALOX15 P16050 2/20 0.42
PTGS1 P23219 1/20 0.42
SLC6A2 P23975 1/20 0.42
MAPK1 P28482 1/20 0.42
PTGS2 P35354 1/20 0.42
HTR2B P41595 1/20 0.42
NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7833466 0.80 EGFR (0.35) MAPTSNCA
SCHEMBL137023 0.70 CA12 (0.39) ALDH1A1HPGDMAPTMEN1KMT2A
SCHEMBL11961726 0.70 ALDH1A1 (0.91) ALDH1A1HSD17B10CYP3A4HPGDMAPT
SCHEMBL2056889 0.68 KDM4E (0.42) ALDH1A1HSD17B10HPGDMEN1KMT2A
SCHEMBL6135801 0.67 ALDH1A1 (0.50) ALDH1A1HSD17B10CYP3A4HPGDAPP
SCHEMBL24865481 0.67 TRIM24 (0.61) ALDH1A1HSD17B10APPMAPTMEN1
SCHEMBL38433 0.67 ALDH1A1 (1.00) ALDH1A1HSD17B10CYP3A4HPGDMAPT
SCHEMBL11466814 0.67 ALDH1A1 (1.00) ALDH1A1HSD17B10CYP3A4HPGDMAPT
Benzene SCHEMBL28342167 0.67 ALDH1A1 (1.00) ALDH1A1HSD17B10CYP3A4HPGDMAPT
SCHEMBL29354421 0.67 ALDH1A1 (1.00) ALDH1A1HSD17B10CYP3A4HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0676398-B1 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO CO (JP) 2001-10-24 EP disclosed
US-6117893-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 2000-09-12 US disclosed
EP-1022274-A1 Oxazolidinedione and Thiazolidinedione derivatves, their preparation and their use Sankyo Company Limited (JP) 2000-07-26 EP disclosed
US-5977365-A HYPOGLYCEMIC AGENTS SANKYO COMPANY, LIMITED (JP) 1999-11-02 US disclosed
US-5962470-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 1999-10-05 US disclosed
US-5834501-A TREATING DIABETES OR HYPERLIPEMIA SANKYO COMPANY, LIMITED (JP) 1998-11-10 US disclosed
US-5739345-A HYPOGLYCEMIC AND ANTIDIABETIC AGENTS SANKYO COMPANY, LIMITED (JP) 1998-04-14 US disclosed
US-5624935-A ANTIDIABETIC AGENTS, HYPOGLYCEMIC AGENTS OR ANTILIPEMIC AGENTS SANKYO COMPANY, LIMITED 1997-04-29 US disclosed